| George Mamdouh Ghobrial, MD | |
|
911 Bypass Rd Bldg A, Pikeville, KY 41501-1689 | |
| (606) 430-2208 | |
| (606) 218-7508 |
| Full Name | George Mamdouh Ghobrial |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 15 Years |
| Location | 911 Bypass Rd Bldg A, Pikeville, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457593428 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | 53004 (Kentucky) | Primary |
| 207T00000X | Neurological Surgery | 2016-02462 (North Carolina) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Pikeville Medical Center | Pikeville, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pikeville Medical Center Inc | 6709790157 | 314 |
News Archive
Braeburn Pharmaceuticals announced today the initiation of a new clinical trial for Probuphine® based on clear guidance from the U.S. Food and Drug Administration (FDA). The study, which was submitted for FDA review in mid-March, is expected to begin enrollment by mid-year and to be completed by the middle of 2015.
Insomnia may have detrimental effects on individuals' kidney health and their overall survival, according to a study that will be presented at ASN Kidney Week 2017 October 31–November 5 at the Ernest N. Morial Convention Center in New Orleans, LA.
A review of a state program launched two years ago to improve recovery and reduce recidivism among felony offenders who have mental health or addiction issues shows the program is producing positive results.
Harborside Healthcare and HHC Nutrition Services will pay the United States $1.375 million to resolve False Claims Act allegations that the company received kickbacks and assistance under the guise of a sham durable medical equipment (DME) provider, the Justice Department announced today.
The flame-retardant mixture known as "Firemaster 550" is an endocrine disruptor that causes extreme weight gain, early onset of puberty and cardiovascular health effects in lab animals, according to a new study spearheaded by researchers from North Carolina State University and Duke University.
› Verified 3 days ago
| Entity Name | Pikeville Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528195864 PECOS PAC ID: 6709790157 Enrollment ID: O20040304001281 |
News Archive
Braeburn Pharmaceuticals announced today the initiation of a new clinical trial for Probuphine® based on clear guidance from the U.S. Food and Drug Administration (FDA). The study, which was submitted for FDA review in mid-March, is expected to begin enrollment by mid-year and to be completed by the middle of 2015.
Insomnia may have detrimental effects on individuals' kidney health and their overall survival, according to a study that will be presented at ASN Kidney Week 2017 October 31–November 5 at the Ernest N. Morial Convention Center in New Orleans, LA.
A review of a state program launched two years ago to improve recovery and reduce recidivism among felony offenders who have mental health or addiction issues shows the program is producing positive results.
Harborside Healthcare and HHC Nutrition Services will pay the United States $1.375 million to resolve False Claims Act allegations that the company received kickbacks and assistance under the guise of a sham durable medical equipment (DME) provider, the Justice Department announced today.
The flame-retardant mixture known as "Firemaster 550" is an endocrine disruptor that causes extreme weight gain, early onset of puberty and cardiovascular health effects in lab animals, according to a new study spearheaded by researchers from North Carolina State University and Duke University.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| George Mamdouh Ghobrial, MD Po Box 432, Pikeville, KY 41502-0432 Ph: (606) 430-2208 | George Mamdouh Ghobrial, MD 911 Bypass Rd Bldg A, Pikeville, KY 41501-1689 Ph: (606) 430-2208 |
News Archive
Braeburn Pharmaceuticals announced today the initiation of a new clinical trial for Probuphine® based on clear guidance from the U.S. Food and Drug Administration (FDA). The study, which was submitted for FDA review in mid-March, is expected to begin enrollment by mid-year and to be completed by the middle of 2015.
Insomnia may have detrimental effects on individuals' kidney health and their overall survival, according to a study that will be presented at ASN Kidney Week 2017 October 31–November 5 at the Ernest N. Morial Convention Center in New Orleans, LA.
A review of a state program launched two years ago to improve recovery and reduce recidivism among felony offenders who have mental health or addiction issues shows the program is producing positive results.
Harborside Healthcare and HHC Nutrition Services will pay the United States $1.375 million to resolve False Claims Act allegations that the company received kickbacks and assistance under the guise of a sham durable medical equipment (DME) provider, the Justice Department announced today.
The flame-retardant mixture known as "Firemaster 550" is an endocrine disruptor that causes extreme weight gain, early onset of puberty and cardiovascular health effects in lab animals, according to a new study spearheaded by researchers from North Carolina State University and Duke University.
› Verified 3 days ago
Damien M Jensen, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 911 Bypass Rd, Pikeville, KY 41501 Phone: 606-218-3925 Fax: 606-218-4560 | |
Norman W Mayer, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 911 Bypass Rd Bldg A, Pikeville, KY 41501 Phone: 606-430-2208 Fax: 606-218-7508 |